Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Oct 28, 2026
Reporting period
Not applicable
Filed with the SEC
Oct 29, 2026
CEOOther
Context
Classification
other
Code P in the derivative table; not an open-market share purchase
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001683168-26-008147
Filed / recorded
Oct 29, 2026, 1:35 PM UTC
Added to OQRO
Oct 29, 2026, 1:40 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
ACTUATE THERAPEUTICS, INC.
Issuer CIK
1652935
Ticker
ACTU
Reporting person
Daniel M Schmitt
Relationship
Director, Officer
Officer title
President, CEO and Director
Security
Warrant to Purchase Common Stock
Table
Derivative (Table II)
Transaction date
Oct 28, 2026
Transaction code
P
Shares / units
70,422
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
70,422
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents detachable warrants acquired on October 28, 2026 in connection with Issuers public offering. For every two shares of common stock acquired in connection with the public offering, one detachable warrant was issued for no additional consideration. The warrant is immediately exercisable and expires 5 years from this issuance date.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
